Controlling the columnar orientation of C3-symmetric "superbenzenes" through alternating polar/apolar substitutents

DOI: 10.1002/anie.200703967

Source and publish data:

Angewandte Chemie - International Edition p. 1703 - 1706 (2008)

Update date:2022-07-30

Topics:

Authors:

Feng, Xinliang

Pisula, Wojciech

Zhi, Linjie

Takase, Masayoshi

Muellen, Klaus

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1002/anie.200703967

Everysecond counts: Enhanced control over the self-organization of discotic compounds has been obtained by introducing alternating arrays of apolar (alkyl) and polar (ester) substitutents on to C₃-symmetric hexa-peri-hexabenzocoronenes. The loc

Full text of DOI:10.1002/anie.200703967

Products guided by the article

Product name:1,4,10-trikis(4'-methoxycarbonylphenyl)-7,13,16-trikis(4'-(3'',7''-dimethyloctanyl)phenyl)-hexa-peri-hexabenzocoronene

Cas No:1018967-73-1

R&D Labs maybe for 1018967-73-1

Anhui Eapearl Chemical Co., Ltd.

Contact:86-562-5858458

Address:358 South Huaihe Road
Nanjing distinctions Medical Technology Co., Ltd.(expird)

Contact:+86-15996203785 13914714059

Address:nanjing,jiangsu , China
FUJIAN SHANSHUI CHEMICAL CORP.LTD.

Contact:+86-151-59920036

Address:Jinqiao Gareden, jo@fj-xinyi.com
Yangzhou Siyu Chemical Co.,Ltd.

Contact:+86-514-87325867 13358126196

Address:Room 620 Exposition Pavilion，No. 98 Huaihai Road,Guangling District，Yangzhou City, Jiangsu Province
Hangzhou Haiqiang Chemical Co.,Ltd.

Contact:+86-571-86960370

Address:Add: 5/F, Around Town North Road,No. 10, Hangzhou, Zhejiang,China

Relevant to this article

SAR optimization studies on a novel series of 2-anilinopyrimidines as selective inhibitors against triple-negative breast cancer cell line MDA-MB-468

Doi:10.1016/j.bmcl.2019.126752
(2019)
Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: The discovery of AZD8055 and AZD2014

Doi:10.1016/j.bmcl.2013.01.019
(2013)
Design, synthesis and evaluation of novel N-phenylbutanamide derivatives as KCNQ openers for the treatment of epilepsy

Doi:10.1016/j.bmcl.2018.05.019
(2018)
SYNTHESIS OF 1,2,4,6-THIATRIAZINE 1,1-DIOXIDES. PART III

Doi:10.1016/S0040-4039(00)89316-8
(1985)
2,3-Disubstituted 8-arylamino-3H-imidazo[4,5-g]quinazolines: A novel class of antitumor agents

Doi:10.1016/j.ejmech.2008.01.009
(2009)
Asymmetric Bronsted acid catalysis: Enantioselective nucleophilic substitutions and 1,4-additions

Doi:10.1002/anie.200703668
(2008)

Article Doi